Poly Medicure Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Poly Medicure Ltd. on BSE

Load latest

Poly Medicure Ltd.

05 Aug 2024

2141.55

5.14%

AGM

POLY MEDICURE LTD. - 531768 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Disclosure of Results of Postal Ballot Meeting held on today i.e 05th August, 2024 along with scrutinizers report.

pdf

Poly Medicure Ltd.

31 Jul 2024

2141.55

5.14%

Earnings Call

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) FRegulations, 2015, we hereby submit Transcript of the investor Meet/Call held on 24th July, 2024, on the Unaudited Financial Results of the Company for the quarter ended 30th June, 224, on Statdalone and Consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 22nd July, 2024.

pdf

Poly Medicure Ltd.

24 Jul 2024

2141.55

5.14%

Earnings Call

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Wednesday, July 24th, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended on June 30, 2024, is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/07/ICI3420240724154379.mp3

pdf

Poly Medicure Ltd.

24 Jul 2024

2141.55

5.14%

Investor Presentation

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the investor''s presentation with respect to Un-audited Financial Results for the first quarter ended on June 30, 2024.

pdf

Poly Medicure Ltd.

22 Jul 2024

2141.55

5.14%

Company Update

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), the Board of directors in its meeting held on today i.e. Monday, July 22, 2024 has appointed vimal Bhandari (DIN: 0001318) as an additional- Non Executive, Independent Director of the Company with effect from 22nd July, 2024, subject to approval of shareholders at the ensuing general meeting of the Company.

pdf

Poly Medicure Ltd.

22 Jul 2024

2141.55

5.14%

Result

POLY MEDICURE LTD. - 531768 - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended …

BSE India

Unaudited Financial Results ( Standalone & Consolidated) for the quarter ended on 30th June, 2024 in compliance of Regulation 30 and 33 of SEBI (LODR) Regulations, 2015

pdf

Poly Medicure Ltd.

22 Jul 2024

2141.55

5.14%

Board Meeting

POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of …

BSE India

Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 22nd July, 2024 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the first quarter ended on 30th June 2024. b) To Re-appoint and Ratification of Remuneration of M/s. Jai Prakash & Company, Cost Accountants as Cost Auditors of the Company for the Financial Year 2024-25, subject to the approval of the shareholders in the forthcoming Annual General Meeting. c) To appoint Mr. Vimal Bhandari (DIN 0001318), as Non-Executive and Independent Director on the Board of the Company, subject to shareholder approval in upcoming Annual general meeting.

pdf

Poly Medicure Ltd.

19 Jul 2024

2141.55

5.14%

Company Update

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Wednesday, 24th July, 2024 at 4.00 p.m. (IST) for discussing the Unaudited Financial Results of the Company for the quarter ended 30th June, 2024. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting. This is for your information and record.

pdf

Poly Medicure Ltd.

17 Jul 2024

2141.55

5.14%

Board Meeting

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting …

BSE India

POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2024 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, notice is hereby given that a meeting of the Board of Director of the Company will be held on Monday, the 22nd July, 2024, inter alia to consider the following: a. To consider and approve the Unaudited Financial Results (Consolidated & Standalone) of the company for the First Quarter ended 30th June, 2024. b. To transact any other matter which the Board may deem fit. In continuation of our intimation regarding closure of trading window vide letter dated 29th June, 2024, the Trading Window for dealing in securities of the company shall remain closed till 24th July, 2024.

pdf

Poly Medicure Ltd.

17 Jul 2024

2141.55

5.14%

Company Update

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Demise

BSE India

The Company regrets to inform about the sad demise of Mr. Prakash Chand Surana (DIN: 00361485), Non-Executive Independent Director of the Company on Wednesday, 17th July, 2024 which has intimated to the Company by the family member of Mr. Prakash Chand Surana today (i.e. 17th July, 2024) We request you to take the above intimation on your record in Compliance with Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Is Poly Medicure Ltd. worth buying?

168 Votes:

Buy 79.76%

Sell 13.69%

Hold 6.55%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf